Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1959 Aug 1;110(2):311–339. doi: 10.1084/jem.110.2.311

STUDIES ON THE MECHANISM OF HYPERSENSITIVITY PHENOMENA

III. THE PARTICIPATION OF COMPLEMENT IN THE FORMATION OF ANAPHYLATOXIN

Abraham G Osler 1, Harry G Randall 1, Betsy M Hill 1, Zoltan Ovary 1
PMCID: PMC2136993  PMID: 13673141

Abstract

The interaction of fresh rat and guinea pig serum with washed preformed immune aggregates has been studied with respect to the loss in hemolytic potency of the serum, diminution of the C'3; activity, and appearance of anaphylatoxin. It has been found that the formation of anaphylatoxin, as judged by its effect on capillary permeability and smooth muscle contraction, is coincident with or subsequent to the fixation of all the known C' components. Less anaphylatoxin is formed by aggregates formed with excess antigen than those in equivalence ratio combination. C' fixation, as well as anaphylatoxin production, may be inhibited by chelation of the divalent cations, presumably by interfering with the fixation of C'1, C'4, and C'2. Phlorizin suppresses the utilization of C'3 in immune hemolysis, C' fixation by antigen-antibody aggregates, and the production of anaphylatoxin. The biological activities associated with the fixation of C' are not manifest unless C'3 participates in this process at 37°C. It is concluded that the formation of anaphylatoxin may be regarded as a product of C' fixation.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMIRAIAN K., PLESCIA O. J., CAVALLO G., HEIDELBERGER M. Complex nature of the step in immune hemolysis involving third component of complement. Science. 1958 Jan 31;127(3292):239–240. doi: 10.1126/science.127.3292.239. [DOI] [PubMed] [Google Scholar]
  2. BIER O. G., SIQUEIRA M. Passive reversed cutaneous anaphylaxis to protein antigens; preliminary report. Int Arch Allergy Appl Immunol. 1955;6(4-6):391–395. doi: 10.1159/000228196. [DOI] [PubMed] [Google Scholar]
  3. BURDON K. L. Present status of the cellular and humoral theories of anaphylaxis. J Pediatr. 1956 Mar;48(3):372–390. doi: 10.1016/s0022-3476(56)80265-5. [DOI] [PubMed] [Google Scholar]
  4. EDLUND T., LOFGREN B., VALI L. Toxicity of dextran in rats. Nature. 1952 Jul 19;170(4316):125–125. doi: 10.1038/170125a0. [DOI] [PubMed] [Google Scholar]
  5. GEMAHLICH M., FRENGER W., SCHEIFFARTH F. Untersuchungen zur Morphologie der Mastzellen im Anaphylatoxinschock beim Meerschweinchen. Int Arch Allergy Appl Immunol. 1958;13(5-8):370–376. [PubMed] [Google Scholar]
  6. GERMUTH F. G., Jr, MCKINNON G. E. Studies on the biological properties of antigen-antibody complexes. I. Anaphylatic shock induced by soluble antigen-antibody complexes in unsensitized normal guinea pigs. Bull Johns Hopkins Hosp. 1957 Jul;101(1):13–44. [PubMed] [Google Scholar]
  7. GIERTZ H., HAHN F., JURNA I., LANGE A. Zur Frage der Beteiligung des Anaphylatoxins im anaphylaktischen Schock. Int Arch Allergy Appl Immunol. 1958;13(3-4):201–212. [PubMed] [Google Scholar]
  8. GRABAR P. Reactions de divers sérums normaux avec des substances macromoléculaires naturelles ou synthétiques. Ann Inst Pasteur (Paris) 1955 Jan;88(1):11–23. [PubMed] [Google Scholar]
  9. GREISMAN S. E. The role of anaphylatoxin during in vitro anaphylaxis. J Immunol. 1958 Sep;81(3):214–219. [PubMed] [Google Scholar]
  10. HAHN F., LANGE A. Das Anaphylatoxin: eine alte Theorie der Anaphylaxie in neuer Sicht. Dtsch Med Wochenschr. 1956 Aug 10;81(32):1269–1274. [PubMed] [Google Scholar]
  11. HAHN F. On anaphylatoxin. Int Arch Allergy Appl Immunol. 1957;11(1-2):119–128. doi: 10.1159/000228407. [DOI] [PubMed] [Google Scholar]
  12. HAINING C. G. Activation of rabbit serum protease by dextran sulphate. Br J Pharmacol Chemother. 1956 Jun;11(2):107–110. doi: 10.1111/j.1476-5381.1956.tb01037.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. HAINING C. G. Histamine release in rabbit blood by dextran and dextran sulphate. Br J Pharmacol Chemother. 1955 Mar;10(1):87–94. doi: 10.1111/j.1476-5381.1955.tb00064.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. HAINING C. G. Inhibition of histamine release by sodium salicylate and other compounds. Br J Pharmacol Chemother. 1956 Dec;11(4):357–363. doi: 10.1111/j.1476-5381.1956.tb00002.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HILL B. M., OSLER A. G. Kinetic studies of complement fixation. II. The role of the aggregating capacity of antibody and its heterogeneity. J Immunol. 1955 Aug;75(2):146–154. [PubMed] [Google Scholar]
  16. HUMPHREY J. H., JAQUES R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol. 1955 Apr 28;128(1):9–27. doi: 10.1113/jphysiol.1955.sp005289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. ISHIZAKA K., CAMPBELL D. H. Biological activity of soluble antigen-antibody complexes. I. Skin reactive properties. Proc Soc Exp Biol Med. 1958 Mar;97(3):635–638. doi: 10.3181/00379727-97-23829. [DOI] [PubMed] [Google Scholar]
  18. JANDL J. H., TOMLINSON A. S. The destruction of red cells by antibodies in man. II. Pyrogenic, leukocytic and dermal responses to immune hemolysis. J Clin Invest. 1958 Aug;37(8):1202–1228. doi: 10.1172/JCI103710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KABAT E. A., BEZER A. E. The effect of variation in molecular weight on the antigenicity of dextran in man. Arch Biochem Biophys. 1958 Dec;78(2):306–318. doi: 10.1016/0003-9861(58)90354-0. [DOI] [PubMed] [Google Scholar]
  20. KABAT E. A., MCDUFFIE F. C. A comparative study of methods used for analysis of specific precipitates in quantitative immunochemistry. J Immunol. 1956 Sep;77(3):193–197. [PubMed] [Google Scholar]
  21. KELLER R. Tissue mast cells in anaphylactic shock and anaphylactoid reactions. Int Arch Allergy Appl Immunol. 1957;11(6):328–341. doi: 10.1159/000228431. [DOI] [PubMed] [Google Scholar]
  22. MAURER P. H., TALMAGE D. W. The effect of the presence of complement in rabbit serum on the quantitative precipitin reaction. II. Effect on antigen and antibody precipitation. J Immunol. 1953 May;70(5):435–440. [PubMed] [Google Scholar]
  23. MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
  24. MONGAR J. L., SCHILD H. O. Effect of temperature on the anaphylactic reaction. J Physiol. 1957 Feb 15;135(2):320–338. doi: 10.1113/jphysiol.1957.sp005713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. MONGAR J. L., SCHILD H. O. The effect of calcium and pH on the anaphylactic reaction. J Physiol. 1958 Feb 17;140(2):272–284. doi: 10.1113/jphysiol.1958.sp005933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MORRISON J. L., RICHARDSON A. P., BLOOM W. L. The effects of antihistaminic agents on the reaction of the rat to dextran. Arch Int Pharmacodyn Ther. 1951 Oct;88(1):98–105. [PubMed] [Google Scholar]
  27. MOTA I. Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats. Br J Pharmacol Chemother. 1957 Dec;12(4):453–456. doi: 10.1111/j.1476-5381.1957.tb00164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Menkin V. STUDIES ON INFLAMMATION : I. FIXATION OF VITAL DYES IN INFLAMED AREAS. J Exp Med. 1929 Jul 31;50(2):171–180. doi: 10.1084/jem.50.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. OSLER A. G., HAWRISIAK M. M., OVARY Z., SIQUEIRA M., BIER O. G. Studies on the mechanism of hypersensitivity phenomena. II. The participation of complement in passive cutaneous anaphylaxis of the albino rat. J Exp Med. 1957 Dec 1;106(6):811–834. doi: 10.1084/jem.106.6.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. OSLER A. G. Quantitative studies of complement fixation. Bacteriol Rev. 1958 Dec;22(4):246–266. doi: 10.1128/br.22.4.246-266.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. PUCHKOV N. V. Rol' glikogenoliticheskikh protsessov v fagotsitarnoi deiatel'nosti leikotsitov krovi. Biokhimiia. 1955 Nov-Dec;20(6):709–713. [PubMed] [Google Scholar]
  33. RAPP H. J. Mechanism of immune hemolysis: recognition of two steps in the conversion of EAC' 1,4,2 to E. Science. 1958 Jan 31;127(3292):234–236. doi: 10.1126/science.127.3292.234-a. [DOI] [PubMed] [Google Scholar]
  34. ROCHA E SILVA M. Concerning the mechanism of anaphylaxis and allergy. Br Med J. 1952 Apr 12;1(4762):779–784. doi: 10.1136/bmj.1.4762.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. ROCHA SILVA E. M., ROTHSCHILD A. M. Experimental design for bioassay of a material inducing strong tachyphylactic effect (anaphylatoxin). Br J Pharmacol Chemother. 1956 Sep;11(3):252–262. doi: 10.1111/j.1476-5381.1956.tb01063.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. TALBOT S. A., LILIENTHAL J. L., Jr, BESER J., REYNOLDS L. W. A wide range mechano-electronic transducer for physiological applications. Rev Sci Instrum. 1951 Apr;22(4):233–236. doi: 10.1063/1.1745898. [DOI] [PubMed] [Google Scholar]
  37. TAYLOR C. E., WALTON K. W. The molecular characteristics determining the anticomplementary activity of dextran sulphates. Br J Exp Pathol. 1957 Jun;38(3):248–255. [PMC free article] [PubMed] [Google Scholar]
  38. VANARSDEL P. P., Jr, MIDDLETON E., Jr, SHERMAN W. B., BUCHWALD H. A quantitative study on the in vitro release of histamine from leukocytes of atopic persons. J Allergy. 1958 Sep;29(5):429–437. doi: 10.1016/0021-8707(58)90084-4. [DOI] [PubMed] [Google Scholar]
  39. VOORHEES A. B., BAKER H. J., PULASKI E. J. Reactions of albino rats to injections of dextran. Proc Soc Exp Biol Med. 1951 Feb;76(2):254–256. doi: 10.3181/00379727-76-18453. [DOI] [PubMed] [Google Scholar]
  40. WALLACE A. L., OSLER A. G., MAYER M. M. Quantitative studies of complement fixation. V. Estimation of complement-fixing potency of immune sera and its relation to antibody-nitrogen content. J Immunol. 1950 Dec;65(6):661–673. [PubMed] [Google Scholar]
  41. WEIGLE W. O., DIXON F. J. Relationship of circulating antigen-antibody complexes, antigen elimination, and complement fixation in serum sickness. Proc Soc Exp Biol Med. 1958 Oct;99(1):226–231. doi: 10.3181/00379727-99-24304. [DOI] [PubMed] [Google Scholar]
  42. WILHELM D. L., MILES A. A., MACKAY M. E. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor. Br J Exp Pathol. 1955 Feb;36(1):82–104. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES